{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T19:16:18Z","timestamp":1726514178838},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Health","award":["AI021548","AI057808","RR03034"],"award-info":[{"award-number":["AI021548","AI057808","RR03034"]}]},{"name":"Research Centers in Minority Institutions Program (RCMI)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.vaccine.2011.12.020","type":"journal-article","created":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T23:07:23Z","timestamp":1323904043000},"page":"1181-1190","source":"Crossref","is-referenced-by-count":1,"title":["CCL5-independent helper T lymphocyte responses to immuno-dominant pneumococcal surface protein A epitopes"],"prefix":"10.1016","volume":"30","author":[{"given":"Rajesh","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailesh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Briles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis D.","family":"Taub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan K.","family":"Hollingshead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"James W.","family":"Lillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.12.020_bib0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1469-0691.2009.02726.x","article-title":"Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae","volume":"3","author":"Dagan","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0010","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1086\/597044","article-title":"Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population","volume":"199","author":"Dagan","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1469-0691.2009.02722.x","article-title":"The public health ramifications of pneumococcal resistance","volume":"3","author":"Reinert","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2334-9-120","article-title":"Risk factors for nasopharyngeal carriage of drug-resistant Streptococcus pneumoniae: data from a nation-wide surveillance study in Greece","volume":"9","author":"Katsarolis","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0025","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.4049\/jimmunol.162.4.1959","article-title":"Lymphotactin acts as an innate mucosal adjuvant","volume":"162","author":"Lillard","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4049\/jimmunol.166.1.162","article-title":"RANTES potentiates antigen-specific mucosal immune responses","volume":"166","author":"Lillard","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0035","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1182\/blood-2002-07-2305","article-title":"MIP-1alpha and MIP-1beta differentially mediate mucosal and systemic adaptive immunity","volume":"101","author":"Lillard","year":"2003","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.vaccine.2011.12.020_bib0040","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0167-5699(98)01346-2","article-title":"Chemokines and chemokine receptors in T-cell priming and Th1\/Th2-mediated responses","volume":"19","author":"Sallusto","year":"1998","journal-title":"Immunol Today"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/84205","article-title":"Chemokines as regulators of T cell differentiation","volume":"2","author":"Luther","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0050","doi-asserted-by":"crossref","first-page":"7419","DOI":"10.1128\/IAI.69.12.7419-7424.2001","article-title":"Mouse strain-dependent chemokine regulation of the genital tract T helper cell type 1 immune response","volume":"69","author":"Darville","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0055","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.4049\/jimmunol.157.8.3598","article-title":"Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response","volume":"157","author":"Schrum","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.187.1.129","article-title":"Differential expression of chemokine receptors and chemotactic responsiveness of type 1T helper cells (Th1s) and Th2s","volume":"187","author":"Bonecchi","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0065","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1126\/science.277.5334.2005","article-title":"Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells","volume":"277","author":"Sallusto","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1471-4906(00)01812-3","article-title":"RANTES: a versatile and controversial chemokine","volume":"22","author":"Appay","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0075","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/clim.2001.5178","article-title":"Impaired T cell function in RANTES-deficient mice","volume":"102","author":"Makino","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0080","first-page":"188","article-title":"Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine","volume":"40","author":"Ifere","year":"2007","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0085","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1073\/pnas.96.8.4581","article-title":"Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression","volume":"96","author":"Liu","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0090","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1097\/00002030-200012010-00006","article-title":"Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study","volume":"14","author":"McDermott","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0095","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.4049\/jimmunol.176.4.2346","article-title":"CCL5 modulates pneumococcal immunity and carriage","volume":"176","author":"Palaniappan","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0100","doi-asserted-by":"crossref","first-page":"e9432","DOI":"10.1371\/journal.pone.0009432","article-title":"Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A","volume":"5","author":"Singh","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0105","first-page":"339","article-title":"Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae","volume":"188","author":"Briles","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/IAI.60.1.111-116.1992","article-title":"Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae","volume":"60","author":"Briles","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0882-4010(95)90125-6","article-title":"Virulence of Streptococcus pneumoniae in mice: a standardized method for preparation and frozen storage of the experimental bacterial inoculum","volume":"18","author":"Aaberge","year":"1995","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0120","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1128\/IAI.68.2.796-800.2000","article-title":"Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae","volume":"68","author":"Briles","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0125","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1128\/IAI.68.2.492-501.2000","article-title":"Host cellular immune response to pneumococcal lung infection in mice","volume":"68","author":"Kadioglu","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0130","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0003-2697(91)90374-3","article-title":"Synthesis of peptide analogues using the multipin peptide synthesis method","volume":"197","author":"Valerio","year":"1991","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0135","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1128\/IAI.73.2.1006-1013.2005","article-title":"Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage","volume":"73","author":"Palaniappan","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0140","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1128\/IAI.72.9.5031-5040.2004","article-title":"PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin","volume":"72","author":"Shaper","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0145","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1074-7613(94)80017-0","article-title":"Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides","volume":"1","author":"Alexander","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0150","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1073\/pnas.86.9.3296","article-title":"Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis","volume":"86","author":"Sette","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0155","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.4049\/jimmunol.157.11.5185","article-title":"Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis","volume":"157","author":"Koedel","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0160","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1182\/blood.V95.8.2505","article-title":"Stromal cell-derived factor-1alpha stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phosphoinositide-3 kinase and protein kinase C","volume":"95","author":"Wang","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0165","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.4049\/jimmunol.172.12.7603","article-title":"IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection","volume":"172","author":"Van der Sluijs","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0170","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.4049\/jimmunol.169.5.2498","article-title":"Cytokine coexpression during human Th1\/Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines","volume":"169","author":"Cousins","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0175","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/1097-4636(200105)55:2<229::AID-JBM1009>3.0.CO;2-Q","article-title":"Selective differentiation of mammalian bone marrow stromal cells cultured on three-dimensional polymer foams","volume":"55","author":"Martin","year":"2001","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0180","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.4049\/jimmunol.181.10.6913","article-title":"Transgenic mice expressing dominant-negative bright exhibit defects in B1 B cells","volume":"181","author":"Nixon","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0185","doi-asserted-by":"crossref","first-page":"7523","DOI":"10.4049\/jimmunol.179.11.7523","article-title":"Transgenic expression of Bcl-xL or Bcl-2 by murine B cells enhances the in vivo antipolysaccharide, but not antiprotein, response to intact Streptococcus pneumoniae","volume":"179","author":"Chattopadhyay","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0190","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.molimm.2009.03.008","article-title":"Virus-like particle vaccine activates conventional B2 cells and promotes B cell differentiation to IgG2a producing plasma cells","volume":"46","author":"Zhang","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0195","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1182\/blood-2010-11-317115","article-title":"Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice","volume":"117","author":"Hansell","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0200","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/eji.200940288","article-title":"Macrophage polarization to a unique phenotype driven by B cells","volume":"40","author":"Wong","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0205","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1128\/IAI.65.7.2975-2977.1997","article-title":"Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia","volume":"65","author":"Pomeroy","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0210","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2567.2008.02986.x","article-title":"Co-operative action of interleukin-10 and interferon-gamma to regulate dendritic cell functions","volume":"127","author":"Yanagawa","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0215","unstructured":"Anonymous. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Technical Report Series, 2000; 894:i-xii, 1-253."},{"key":"10.1016\/j.vaccine.2011.12.020_bib0220","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/MLR.0b013e3181a80fdc","article-title":"Racial and ethnic disparities in pneumonia treatment and mortality","volume":"47","author":"Hausmann","year":"2009","journal-title":"Med Care"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0225","first-page":"227","article-title":"Pneumococcal pneumonia: epidemiology and clinical features","volume":"14","author":"Marrie","year":"1999","journal-title":"Semin Respir Infect"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0230","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archinte.160.1.89","article-title":"Invasive pneumococcal infection in Baltimore, Md: implications for immunization policy","volume":"160","author":"Harrison","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0235","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1084\/jem.165.2.381","article-title":"Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA)","volume":"165","author":"McDaniel","year":"1987","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2011.12.020_bib0240","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1128\/IAI.57.7.2037-2042.1989","article-title":"Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae","volume":"57","author":"Berry","year":"1989","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11019438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11019438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T21:09:44Z","timestamp":1686517784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11019438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0264410X11019438"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}